Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction

Toxicology and Applied Pharmacology

Volumn 230, Issue 3, 2008, Pages 383-389

  Wang, Xiao Jun ^a   Sun, Zheng ^a   Chen, Weimin ^a   Li, Yanjie ^a   Villeneuve, Nicole F ^a   Zhang, Donna D ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Arsenic; Cul3; E3 ubiquitin ligase; Keap1; Nrf2

Indexed keywords

ARSENIC; ARSENIC DERIVATIVE; CUL3 E3 UBIQUITIN LIGASE; CYSTEINE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MONOMETHYLARSONOUS ACID; SULFORAPHANE; TERT BUTYLHYDROQUINONE; TRANSCRIPTION FACTOR NRF2; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; ENZYME ACTIVITY; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION;

ARSENITES; CELL LINE, TUMOR; CULLIN PROTEINS; CYSTEINE; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-E2-RELATED FACTOR 2; ORGANOMETALLIC COMPOUNDS; UBIQUITIN-PROTEIN LIGASES;

EID: 46749152185     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.03.003     Document Type: Article

References (46)

1. Bae D.S., Hanneman W.H., Yang R.S., and Campain J.A. Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treatment in human keratinocytes: application of cDNA microarray technology. Environ. Health Perspect. 110 Suppl 6 (2002) 931-941
2. Benbrahim-Tallaa L., Waterland R.A., Styblo M., Achanzar W.E., Webber M.M., and Waalkes M.P. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol. Appl. Pharmacol. 206 (2005) 288-298
3. Bredfeldt T.G., Jagadish B., Eblin K.E., Mash E.A., and Gandolfi A.J. Monomethylarsonous acid induces transformation of human bladder cells. Toxicol. Appl. Pharmacol. 216 (2006) 69-79
4. Byrd D.M., Roegner M.L., Griffiths J.C., Lamm S.H., Grumski K.S., Wilson R., and Lai S. Carcinogenic risks of inorganic arsenic in perspective. Int. Arch. Occup. Environ. Health 68 (1996) 484-494
5. Chen C.J., Chen C.W., Wu M.M., and Kuo T.L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 66 (1992) 888-892
6. Chen H., Liu J., Zhao C.Q., Diwan B.A., Merrick B.A., and Waalkes M.P. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol. Appl. Pharmacol. 175 (2001) 260-268
7. Chen H., Li S., Liu J., Diwan B.A., Barrett J.C., and Waalkes M.P. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 25 (2004) 1779-1786
8. Cullinan S.B., Gordan J.D., Jin J., Harper J.W., and Diehl J.A. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell Biol. 24 (2004) 8477-8486
9. Eggler A.L., Luo Y., van Breemen R.B., and Mesecar A.D. Identification of the highly reactive cysteine 151 in the chemopreventive agent-sensor keap1 protein is method-dependent. Chem. Res. To.xicol. (2007)
10. Furukawa M., and Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell Biol. 25 (2005) 162-171
11. Hamadeh H.K., Trouba K.J., Amin R.P., Afshari C.A., and Germolec D. Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes. Toxicol Sci. 69 (2002) 306-316
12. He X., Chen M.G., Lin G.X., and Ma Q. Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2 × Keap1 × Cul3 complex and recruiting Nrf2 × Maf to the antioxidant response element enhancer. J .Biol. Chem. 281 (2006) 23620-23631
13. Jain A.K., Bloom D.A., and Jaiswal A.K. Nuclear import and export signals in control of Nrf2. J. Biol. Chem. 280 (2005) 29158-29168
14. Karapetian R.N., Evstafieva A.G., Abaeva I.S., Chichkova N.V., Filonov G.S., Rubtsov Y.P., Sukhacheva E.A., Melnikov S.V., Schneider U., Wanker E.E., and Vartapetian A.B. Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol. Cell Biol. 25 (2005) 1089-1099
15. Kensler T.W., Wakabayashi N., and Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 89-116
16. Kimura A., Ishida Y., Hayashi T., Wada T., Yokoyama H., Sugaya T., Mukaida N., and Kondo T. Interferon-gamma plays protective roles in sodium arsenite-induced renal injury by up-regulating intrarenal multidrug resistance-associated protein 1 expression. Am. J. Pathol. 169 (2006) 1118-1128
17. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172 (2001) 249-261
18. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., and Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell Biol. 24 (2004) 7130-7139
19. Kobayashi M., and Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul. 46 (2006) 113-140
20. Lamm S.H., Engel A., Kruse M.B., Feinleib M., Byrd D.M., Lai S., and Wilson R. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. J. Occup. Environ. Med. 46 (2004) 298-306
21. Levonen A.L., Landar A., Ramachandran A., Ceaser E.K., Dickinson D.A., Zanoni G., Morrow J.D., and Darley-Usmar V.M. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 378 (2004) 373-382
22. Li J., Gorospe M., Barnes J., and Liu Y. Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts. J. Biol. Chem. 278 (2003) 13183-13191
23. Liu J., Xie Y., Ward J.M., Diwan B.A., and Waalkes M.P. Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic. Toxicol. Sci. 77 (2004) 249-257
24. Lo S.C., and Hannink M. CAND1-mediated substrate adaptor recycling is required for efficient repression of Nrf2 by Keap1. Mol. Cell Biol. 26 (2006) 1235-1244
25. Luo Y., Eggler A.L., Liu D., Liu G., Mesecar A.D., and van Breemen R.B. Sites of alkylation of human keap1 by natural chemoprevention agents. J. Am. Soc. Mass. Spectrom. 18 (2007) 2226-2232
26. Mahata J., Ghosh P., Sarkar J.N., Ray K., Natarajan A.T., and Giri A.K. Effect of sodium arsenite on peripheral lymphocytes in vitro: individual susceptibility among a population exposed to arsenic through the drinking water. Mutagenesis 19 (2004) 223-229
27. Massrieh W., Derjuga A., and Blank V. Induction of endogenous Nrf2/small maf heterodimers by arsenic-mediated stress in placental choriocarcinoma cells. Antioxid. Redox Signal. 8 (2006) 53-59
28. Nguyen T., Sherratt P.J., Nioi P., Yang C.S., and Pickett C.B. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J. Biol. Chem. 280 (2005) 32485-32492
29. Petzoldt J.L., Leigh I.M., Duffy P.G., Sexton C., and Masters J.R. Immortalisation of human urothelial cells. Urol. Res. 23 (1995) 377-380
30. Pi J., Qu W., Reece J.M., Kumagai Y., and Waalkes M.P. Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp. Cell Res. 290 (2003) 234-245
31. Pott W.A., Benjamin S.A., and Yang R.S. Antagonistic interactions of an arsenic-containing mixture in a multiple organ carcinogenicity bioassay. Cancer Lett. 133 (1998) 185-190
32. Romach E.H., Zhao C.Q., Del Razo L.M., Cebrian M.E., and Waalkes M.P. Studies on the mechanisms of arsenic-induced self tolerance developed in liver epithelial cells through continuous low-level arsenite exposure. Toxicol Sci. 54 (2000) 500-508
33. Shimizu M., Hochadel J.F., Fulmer B.A., and Waalkes M.P. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro. Toxicol Sci. 45 (1998) 204-211
34. Smith A.H., Lingas E.O., and Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull. World Health Organ. 78 (2000) 1093-1103
35. Snow E.T., Sykora P., Durham T.R., Klein, and C.B. Arsenic, mode of action at biologically plausible low doses: What are the implications for low dose cancer risk?. Toxicol. Appl. Pharmacol. 207 (2005) 557-564
36. Sun Z., Zhang S., Chan J.Y., and Zhang D.D. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell Biol. 27 (2007) 6334-6349
37. Tchounwou P.B., Wilson B., and Ishaque A. Important considerations in the development of public health advisories for arsenic and arsenic-containing compounds in drinking water. Rev. Environ. Health 14 (1999) 211-229
38. Tchounwou P.B., Patlolla A.K., and Centeno J.A. Carcinogenic and systemic health effects associated with arsenic exposure-a critical review. Toxicol. Pathol. 31 (2003) 575-588
39. Velichkova M., and Hasson T. Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism. Mol. Cell Biol. 25 (2005) 4501-4513
40. Wakabayashi N., Dinkova-Kostova A.T., Holtzclaw W.D., Kang M.I., Kobayashi A., Yamamoto M., Kensler T.W., and Talalay P. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2040-2045
41. Wang X.J., Sun Z., Chen W., Eblin K.E., Gandolfi J.A., and Zhang D.D. Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. Toxicol. Appl. Pharmacol. 225 (2007) 206-213
42. Yih L.H., Peck K., and Lee T.C. Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis 23 (2002) 867-876
43. Zhang D.D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug. Metab. Rev. 38 (2006) 769-789
44. Zhang D.D., and Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell Biol. 23 (2003) 8137-8151
45. Zhang D.D., Lo S.C., Cross J.V., Templeton D.J., and Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell Biol. 24 (2004) 10941-10953
46. Zheng X.H., Watts G.S., Vaught S., and Gandolfi A.J. Low-level arsenite induced gene expression in HEK293 cells. Toxicology 187 (2003) 39-48